Pharmacotherapy of obesity: An update.

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Andrea CignarellaRoberto Vettor

Abstract

Several pharmacological approaches to controlling body weight have been developed over the last decades, albeit with limited success. Currently available agents include centrally acting appetite suppressants and peripherally acting compounds. Efficacy and safety of these agents in the clinical setting require a difficult balance. Further strategies including multiagonists able to simultaneously target multiple actors involved in obesity initiation and expansion such as the glucagon receptor family are under investigation. The results of recent clinical trials are encouraging and highlight emerging compounds as potential game changers. In view of the rising prevalence of obesity and the associated burden of comorbidities worldwide, and compared with other areas of pharmacological intervention, we feel that the field of obesity has been affected by therapeutic inertia. Of note, obesity may also affect the response to concomitant medications such as low-dose aspirin. Lessons from withdrawn agents such as the cannabinoid receptor antagonist rimonabant include developing compounds with a more targeted action profile (i.e., central vs peripheral, or antagonist versus inverse agonist) as well as careful selection of patients based on ...Continue Reading

References

Oct 23, 1997·The New England Journal of Medicine·R D HurtP M Sullivan
Apr 15, 2000·The New England Journal of Medicine·E Colman, M Fossler
Jul 18, 2002·Nature Reviews. Drug Discovery·Vivion E F CrowleyStephen O'Rahilly
Aug 5, 2003·The Journal of Clinical Investigation·Daniela CotaUberto Pagotto
Sep 17, 2003·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·R PadwalD C W Lau
Sep 14, 2004·Primary Care Companion to the Journal of Clinical Psychiatry·Stephen M. StahlSusan Learned-Coughlin
Nov 26, 2004·Drugs·Monique P Curran, Lesley J Scott
Feb 7, 2008·The Journal of Pharmacology and Experimental Therapeutics·William J ThomsenDominic Behan
Oct 13, 2009·The Journal of Clinical Endocrinology and Metabolism·J SmithP Marceau
May 19, 2010·International Journal of Obesity : Journal of the International Association for the Study of Obesity·A SjödinA Astrup
Jun 3, 2011·Clinical Pharmacology and Therapeutics·R JainC G Sahajwalla
Jan 28, 2012·AIDS Research and Human Retroviruses·Stephen J Kent
Mar 1, 2012·Diabetes & Metabolism Journal·Jun Goo Kang, Cheol-Young Park
Oct 16, 2012·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Marjolein J C WillemenToine C G Egberts
May 11, 2013·Circulation. Cardiovascular Imaging·Neil J WeissmanChristen M Anderson
Jul 16, 2013·Lancet·Arne AstrupThomas M Larsen
Sep 4, 2013·International Journal of Obesity : Journal of the International Association for the Study of Obesity·J van CanW H M Saris
Jun 25, 2015·Drugs·Sarah L Greig, Gillian M Keating
Jul 3, 2015·The New England Journal of Medicine·Xavier Pi-SunyerUNKNOWN SCALE Obesity and Prediabetes NN8022-1839 Study Group
Feb 13, 2016·Lancet·George A BrayJohn P H Wilding
Sep 17, 2016·The New England Journal of Medicine·Steven P MarsoUNKNOWN SUSTAIN-6 Investigators
Apr 11, 2017·Obesity Science & Practice·A MehtaI J Neeland
Oct 14, 2017·Nature Reviews. Endocrinology·Gitanjali Srivastava, Caroline M Apovian
Oct 17, 2017·Molecular Metabolism·Luke K BurkeLora K Heisler
Oct 17, 2017·The Journal of Clinical Investigation·Inigo Ruiz de AzuaBeat Lutz
Nov 16, 2017·Clinical Pharmacokinetics·Nicholas B Norgard
Jun 16, 2018·Endocrine Reviews·Megan E CapozziJonathan E Campbell
Aug 2, 2018·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·F-F WangP J Hardiman
Aug 28, 2018·The New England Journal of Medicine·Erin A BohulaUNKNOWN CAMELLIA–TIMI 61 Steering Committee and Investigators

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Family Practice
B Budenholzer
Journal of Obesity & Metabolic Syndrome
Bo-Yeon KimCommittee of Clinical Practice Guidelines, Korean Society for the Study of Obesity (KSSO)
© 2021 Meta ULC. All rights reserved